Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
That's $400 a month," stated Favella
"Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes." Journal of Clinical Investigation
Finsterer J
The Clinical Reality Check: STEP 1, STEP 4, SELECT, and the 52% Dropout Trial data and real-world data tell two different stories
Patients with polycystic ovary syndrome (PCOS) who have both insulin resistance and obesity might benefit from this combination, as metformin is commonly used off-label in PCOS management (NICE CKS) and Wegovy can address weight-related aspects of the condition
For example, tirzepatide may reduce the effectiveness of oral contraceptives, and patients taking warfarin with any GLP-1 receptor agonist should consider more frequent INR monitoring when starting or stopping therapy
